Acorda Therapeutics Inc Stock Price (ACOR)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

956 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Cetera Investment AdvisersTue, 6 Dec 2022 05:44:42 UTC via ETF Daily News
BNP Paribas Arbitrage SA Purchases 5,872 Shares of Simpson Manufacturing Co., Inc. (NYSE:SSD)Tue, 6 Dec 2022 05:36:48 UTC via ETF Daily News
Deutsche Bank AG Increases Position in Beam Therapeutics Inc. (NASDAQ:BEAM)Tue, 6 Dec 2022 05:24:46 UTC via ETF Daily News
Rhumbline Advisers Boosts Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Tue, 6 Dec 2022 05:10:45 UTC via ETF Daily News
Denali Therapeutics (NASDAQ:DNLI) Coverage Initiated by Analysts at CowenTue, 6 Dec 2022 03:52:47 UTC via ETF Daily News
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of “Moderate Buy” from BrokeragesTue, 6 Dec 2022 03:46:45 UTC via ETF Daily News
Short Interest in Capricor Therapeutics Inc (NASDAQ:CAPR) Increases By 5.3%Tue, 6 Dec 2022 03:42:43 UTC via ETF Daily News
Y-mAbs Therapeutics (NASDAQ:YMAB) PT Raised to $27.00Tue, 6 Dec 2022 03:38:52 UTC via ETF Daily News
Wells Fargo & Company Begins Coverage on Travere Therapeutics (NASDAQ:TVTX)Tue, 6 Dec 2022 03:38:52 UTC via ETF Daily News
Chinook Therapeutics (NASDAQ:KDNY) Coverage Initiated at Wells Fargo & CompanyTue, 6 Dec 2022 03:38:52 UTC via ETF Daily News

Acorda Therapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACOR

You don't have any alerts set for IEX:ACOR.

About Acorda Therapeutics Inc

Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA® (levodopa inhalation powder) is approved for intermittent treatment of OFF episodes in adults with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last two weeks. INBRIJA utilizes Acorda's innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Acorda also markets the branded AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

CEORon Cohen IndustryBiological Product (except Diagnostic) Manufacturing SectorManufacturing Websitewww.acorda.com Issue ExchangeNASDAQ Issue TypeUnknown

Real-time ACOR to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.